Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
Chr t(11;14)
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(21)
News
Trials
Search handles
@SLentzsch
@ninashah33
Search handles
@SLentzsch
@ninashah33
Filter by
Latest
12ms
Excellent 👍🏻presentation on the biology of t11,14 Myeloma by @Rfonsi1 @COMyCongress -Time to call t11;14 a separate MM entity and to treat it differently from the beginning!! @Mohty_EBMT #mmsm (@SLentzsch)
12 months ago
Chr t(11;14)
over2years
Bellini trial shows longest PFS in t11;14 and BCL2 high in myeloma patients @myelomaMD #mmsm #ASH21 @genentech (@SLentzsch)
over 2 years ago
Clinical
|
BCL2 (B-cell CLL/lymphoma 2)
|
Chr t(11;14)
over3years
When CVA is a good thing: Novel combination of (cobimetinib +/-ven) +/- atezolizumab. Encouraging responses (not surprisingly) mainly in t11:14 and even more with ras mutation. Moving towards biomarker driven tx in #myeloma. Also can we pls resurrect PD-L1 targeting? #mmsm #ASH20 (@ninashah33)
over 3 years ago
PD(L)-1 Biomarker
|
PD-L1 (Programmed death ligand 1)
|
Chr t(11;14)
|
Tecentriq (atezolizumab) • Cotellic (cobimetinib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login